Curated gurus reporting this holding
A curated subset of well-known investors — not the full institutional ownership.
- Bridgewater Associates455,392주2026-06-30 · 증감 +159813주
- Duquesne Family Office1,424,690주2026-06-30 · 증감 +270600주
$103.83-6.56%
2026-10-05 closeInsmed's company information is shown as of 2026-10-05. It is a security listed on Nasdaq, ticker INSM. There are 12 published related companies.
About this company
Insmed last closed at $103.83 (-6.56%) on 2026-10-05. Listed on Nasdaq.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F is quarterly and may be filed up to 45 days later.
Suppliers, competitors and related stocks
- AstraZenecaCompetitor
폐질환·희귀질환 치료제 시장에서 경쟁
- GSKCompetitor
호흡기 질환 및 희귀질환 치료제 분야 경쟁
- Vertex PharmaceuticalsCompetitor
희귀질환 중심 바이오텍 경쟁사
- AbbVieCompetitor
면역·염증성 질환 치료제 시장에서 경쟁
- NovartisCompetitor
호흡기·희귀질환 및 전문의약품 시장 경쟁
- Boehringer IngelheimCompetitor
호흡기 질환 치료제 개발에서 경쟁
- Nektar TherapeuticsCompetitor
염증·면역질환 파이프라인 경쟁
- CiplaCompetitor
흡입·호흡기 치료제 및 제네릭 기반 경쟁
- BronchiectasisRelated theme
Insmed의 핵심 타깃 시장인 기관지확장증 치료 테마
- Non-tuberculous mycobacterial lung diseaseRelated theme
Insmed의 주요 적응증 중 하나인 비결핵항산균 폐질환 테마
- Cystic fibrosisRelated theme
호흡기 희귀질환 치료 테마로 일부 파이프라인과 연관
- Pulmonary arterial hypertensionRelated theme
흡입 치료제 등 개발과 연결되는 폐고혈압 테마
Major stocks in the same sector
2026-10-06 dataset
📦 ETFs holding this stock
by weight · top-10 constituents basisPassive money holding this stock ≈ $1M(lower bound — top-10 basis, not a forecast)
Factual holdings info from daily disclosures — not a recommendation.
Look up another stock →Quantus Signal · live data · not investment advice · Privacy Policy